BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8180425)

  • 1. Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha.
    Ambrosetti A; Krampera M; Veneri D; Meneghini V; Aprili F; Martinelli G; Pizzolo G; Perona G
    Int J Clin Lab Res; 1994; 24(1):58-9. PubMed ID: 8180425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
    Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM; Talpaz M
    Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract]   [Full Text] [Related]  

  • 4. Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
    Kawakubo K; Ohyashiki JH; Ohyashiki K; Tauchi T; Ohto T; Toyama K
    Cancer Genet Cytogenet; 1992 Feb; 58(2):165-8. PubMed ID: 1551082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extramedullary blast crisis in chronic myeloid leukemia.
    Specchia G; Palumbo G; Pastore D; Mininni D; Mestice A; Liso V
    Leuk Res; 1996; 20(11-12):905-8. PubMed ID: 9009247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Meloni G; Capria S; Vignetti M; Mandelli F; Modena V
    Blood; 1997 Jun; 89(12):4659. PubMed ID: 9192793
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
    Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.
    Fabbiano F; Santoro A; Di Trapani F; Marino MA; Pampinella M; Caronia F
    Eur J Haematol; 1993 Aug; 51(2):122-3. PubMed ID: 8370420
    [No Abstract]   [Full Text] [Related]  

  • 9. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11).
    Li L; Ritterbach J; Harbott J; Schroyens W; Lohmeyer J; Pralle H; Lampert F
    Cancer Genet Cytogenet; 1993 Jul; 68(2):131-4. PubMed ID: 8353804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.
    Meloni G; Foà R; Tosti S; Vignetti M; Gavosto F; Mandelli F
    Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; Keating MJ; Estey EH; O'Brien S; Beran M; McCredie KB; Gutterman J; Freireich EJ
    Cancer; 1991 Sep; 68(6):1201-7. PubMed ID: 1873771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia.
    Cağirgan S; Sencan M; Tombuloglu M; Ozdemir E; Hekimgil M; Büyükkeçeci F
    Leuk Lymphoma; 1998 Apr; 29(3-4):423-5. PubMed ID: 9684940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very long survival in complete cytogenetic remission in an adolescent with lymphoid blast crisis of chronic myeloid leukemia after treatment with intensive ALL-directed chemotherapy combined with continuous imatinib.
    Maschan A; Novichkova G; Miakova N; Persiantseva M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2243-2245. PubMed ID: 27434016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation.
    Liang R; Chan TK; Chiu E; Todd D
    Cancer Chemother Pharmacol; 1992; 29(4):323-5. PubMed ID: 1537081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon therapy for chronic myelogenous leukemia].
    Shibata A; Hashimoto S
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.
    Haematologica; 1992; 77(3):204-14. PubMed ID: 1427426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate.
    Kanda Y; Chiba S; Honda H; Hirai H; Yazaki Y
    Leuk Lymphoma; 1999 Mar; 33(1-2):193-7. PubMed ID: 10194138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.